Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-08T12:23:23.580Z Has data issue: false hasContentIssue false
  • English
  • Français

Administration of bovine anti-IGF-1 immunoglobulin to dietary protein deficient rats alters dietary intake and plasma IGF-1 binding profiles, but does not affect change in body mass

Published online by Cambridge University Press:  05 May 2010

N. N. Smith ,
M. J. Kelly ,
J. M. Pell  and
R. A. Hill
N. N. Smith
Affiliation:
Central Queensland University, Rockhampton, Australia
M. J. Kelly
Affiliation:
University of New England, Armidale, Australia
J. M. Pell
Affiliation:
Molecular Signalling Laboratory, The Babraham Institute, Cambridge, CB22 3AT, UK
R. A. Hill*
Affiliation:
Animal and Veterinary Science, University of Idaho, 311 Agricultural Biotechnology Building, PO Box 442330, Moscow, Idaho 83844-2330, USA
*
†E-mail: [email protected]
Get access

Abstract

The potential of antibodies raised against insulin-like growth factor-1 (IGF-1) as a treatment to enhance the anabolic actions of IGF-1 has been demonstrated in both rodent and ruminant models. We investigated whether treatment of genetically normal rats with anti-IGF-1 immunoglobulin (Ig, raised in cattle) would enhance growth and if anti-IGF-1 Ig treatment would ameliorate live-weight loss in genetically normal rats offered a severely protein-restricted diet. Scatchard analysis was used to characterise ammonium sulphate precipitated bovine anti-IGF-1 Ig. Anti-IGF-1 Ig binding to 125I-IGF-1 yielded an almost linear Scatchard plot, with a Hill co-efficient of 0.951 ± 0.012, indicating a single class of IGF-1 binding sites. The affinity of anti-IGF-1 Ig for IGF-1 was 2.14 ± 0.66 × 109 l/mol. The non-immune Ig preparation did not bind IGF-1. Rats were offered either a diet with a normal protein level (20%) or protein restricted (4% protein), and each dietary group was further treated with twice-daily i.p. injections of either diluent phosphate buffered saline, non-immune Ig or anti-IGF-1 Ig. Dietary protein level had a significant effect on live-weight gain, but there was no effect of non-immune Ig or anti-IGF-1 Ig on live-weight gain. Treatment with anti-IGF-1 Ig prevented the significant depression of cumulative dietary intake observed in diluent, and non-immune Ig treated groups offered the 4% protein diet. The cumulative dietary intake of the anti-IGF-1 Ig treated, 4% dietary protein group did not differ significantly from those of the groups offered the 20% protein diet. In addition, within the 4% dietary protein group, rats treated with non-immune Ig exhibited a cumulative feed intake that was intermediate between that of the diluent treated and anti-IGF-1 Ig treated groups (P < 0.05). Size exclusion chromatography was used to characterise in vitro125I-IGF-1 binding in end-point plasma from each treatment group. In comparison to control groups, anti-IGF-1 Ig treatment resulted in substantially increased 125I-IGF-1 binding in the 30 to 40 kDa region and a concomitant reduction in elution of free 125I-IGF-1. Protein restriction markedly depressed IGF-1 binding at ∼150 kDa in the plasma of diluent and non-immune Ig treated groups. Anti-IGF-1 Ig treatment was effective in preventing this decrease in ∼150 kDa binding. Thus, anti-IGF-1 Ig appears to have a beneficial effect on dietary intake in protein-restricted rats, which is associated with induced changes in IGF-1 binding profiles in plasma.

Keywords

immunomodulationIGF-1catabolismpassive immunisation
Type
Full Paper
Information
animal , Volume 4 , Issue 9 , September 2010 , pp. 1553 - 1560
Copyright
Copyright © The Animal Consortium 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ballard, FJ, Knowles, SE, Walton, PE, Edson, K, Owens, PC, Mohler, MA, Ferraiolo, BL 1991. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3) IGF-I in rats. Journal of Endocrinology 128, 197–204.CrossRefGoogle ScholarPubMed
Böni-Schnetzler, M, Hauri, C, Zapf, J 1999. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats. Diabetologica 42, 160–166.CrossRefGoogle ScholarPubMed
Botfield, C, Ross, RJM, Hinds, CJ 1997. The role of IGFs in catabolism. Baillière’s Clinical Endocrinology and Metabolism 11, 679–697.CrossRefGoogle ScholarPubMed
Breier, BH, Gluckman, PD, Bass, JJ 1988. Influence of nutritional status and oestradiol-17β on plasma growth hormone, insulin-like growth factors-I and -II and the response to exogenous growth hormone in young steers. Journal of Endocrinology 118, 243–250.CrossRefGoogle ScholarPubMed
Butler, AA, LeRoith, D 2001. Minireview: tissue-specific versus generalized gene targeting of the IGF1 and IGFr genes and their roles in insulin-like growth factor physiology. Endocrinology 142, 1685–1688.CrossRefGoogle ScholarPubMed
Cerra, FB, Siegel, JH, Coleman, B, Border, JR, McMenamy, R 1980. Septic autocannibalism: a failure of exogenous nutritional support. Annals of Surgery 192, 570–580.CrossRefGoogle ScholarPubMed
Clemmons, DR 2009. Role of IGF-I in skeletal muscle mass maintenance. Trends in Endocrinology & Metabolism 20, 349–356.CrossRefGoogle ScholarPubMed
Clemmons, DR, Smith-Banks, A, Underwood, LE 1992. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. Journal of Clinical Endocrinology and Metabolism 75, 234–238.Google ScholarPubMed
Conover, CA 1992. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130, 3191–3199.CrossRefGoogle ScholarPubMed
Du, F, Higginbotham, A, White, BD 2000. Food intake, energy balance and serum leptin concentrations in rats fed low-protein diets. Journal of Nutrition 130, 514–521.CrossRefGoogle ScholarPubMed
Elsasser, TH, Rumsey, TS, Hammond, AC, Fayer, R 1988. Inflluence of parasitism on plasma concentrations of growth hormone, somatomedin-C and somatomedin binding proteins in calves. Journal of Endocrinology 116, 191–200.CrossRefGoogle Scholar
Forbes, JM 2000. Physiological and metabolic aspects of feed intake control. In Farm Animal Metabolism and Nutrition (ed. JPF D’Mello), pp. 319–333. CABI Publishing, Wallingford, UK.CrossRefGoogle Scholar
Gibson, FAM, Hinds, CJ 1997. Growth hormone and insulin-like growth factors in critical illness. Intensive Care Medicine 23, 369–378.CrossRefGoogle ScholarPubMed
Hill, RA, Pell, JM 1998. Regulation of insulin-like growth factor 1 (IGF-1) bioactivity in vivo: further characterisation of an IGF-1-enhancing antibody. Endocrinology 139, 1278–1287.CrossRefGoogle ScholarPubMed
Hill, RA, Smith, NN, Holmes, MA 1998a. An insulin-like growth factor-1 (IGF-1) based vaccine improves growth rate in steers. Animal Production in Australia 22, 321.Google Scholar
Hill, RA, Flick-Smith, HC, Dye, S, Pell, JM 1997. Actions of an IGF-I enhancing antibody on IGF-I pharmacokinetics and tissue distribution: increased IGF-I bioavailability. Journal of Endocrinology 152, 123–130.CrossRefGoogle ScholarPubMed
Hill, RA, Gazzola, C, Herd, RM, Oddy, VH 1998b. An insulin-like growth factor-1 based vaccine changes body composition in Angus steers. Proceedings of the Nutrition Society of Australia 22, 176.Google Scholar
Hill, RA, Hunter, RA, Lindsay, DB, Owens, PC 1999. Action of long(R3)-insulin-like growth factor-1 on protein metabolism in beef heifers. Domestic Animal Endocrinology 16, 219–229.CrossRefGoogle ScholarPubMed
Hossner, KL, McCusker, RH, Dodson, MV 1997. Insulin-like growth factors and their binding proteins in domestic animals. Animal Science 64, 1–15.CrossRefGoogle Scholar
Jacob, R, Barrett, E, Plewe, G, Fagin, KD, Sherwin, RS 1989. Acute effects of insulin-like growth factor-1 on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. Journal of Clinical Investigation 83, 1717–1723.CrossRefGoogle ScholarPubMed
Jacob, R, Hu, X, Niederstock, D, Hasan, S, McNulty, PH, Sherwin, RS, Young, LH 1996. IGF-I stimulation of muscle protein synthesis in the awake rat: permissive role of insulin and amino acids. American Journal of Physiology 33, E60–E66.Google Scholar
Katsumata, M, Kawakami, S, Kaji, Y, Takada, R, Dauncey, MJ 2002. Differential regulation of porcine hepatic IGF-I mRNA expression and plasma IGF-I concentration by a low lysine diet. Journal of Nutrition 132, 688–692.CrossRefGoogle ScholarPubMed
Kerr, DE, Laarveld, B, Manns, JG 1990. Effects of passive immunization of growing guinea-pigs with an insulin-like growth factor-I monoclonal antibody. Journal of Endocrinology 124, 403–415.CrossRefGoogle ScholarPubMed
Koea, JB, Douglas, RG, Breier, BH, Shaw, JHF, Gluckman, PD 1992. Synergistic effect of insulin-like growth factor-I administration on the protein-sparing effects of total parenteral nutrition in fasted lambs. Endocrinology 131, 643–648.Google ScholarPubMed
LaPaglia, N, Steiner, J, Kirsteins, L, Emanuele, M, Emanuele, N 1998. Leptin alters the response of the growth hormone releasing factor-growth hormone-insulin-like growth factor-I axis to fasting. Journal of Endocrinology 159, 79–83.CrossRefGoogle ScholarPubMed
Leury, BJ, Baumgard, LH, Block, SS, Segoale, N, Ehrhardt, RA, Rhoads, RP, Bauman, DE, Bell, AW, Boisclair, YR 2003. Effect of insulin and growth hormone on plasma leptin in periparturient dairy cows. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 285, R1107–R1115.CrossRefGoogle ScholarPubMed
McPherson, GA 1985. Analysis of radioligand binding experiments: a collection of computor programs for the IBM. Journal of Pharmacological Methods 14, 213–228.CrossRefGoogle Scholar
Miura, Y, Kato, H, Noguchi, T 1992. Effect of dietary proteins on insulin-like growth factor-1 (IGF-1) messenger ribonucleic acid content in rat liver. British Journal of Nutrition 67, 257–265.CrossRefGoogle ScholarPubMed
Moller, AV, Jorgensen, SP, Chen, JW, Larnkjaer, A, Ledet, T, Flyvbjerg, A, Frystyk, J 2006. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro. European Journal of Endocrinology 155, 297–305.CrossRefGoogle ScholarPubMed
Munson, PJ, Rodbard, D 1980. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analytical Biochemistry 107, 220–239.CrossRefGoogle ScholarPubMed
Nass, R, Thorner, MO 2002. Impact of the GH-cortisol ratio on the age-dependent changes in body composition. Growth Hormone & IGF Research 12, 147–161.CrossRefGoogle ScholarPubMed
O’Connor, PMJ, Bush, JA, Suryawan, A, Nguyen, HV, Davis, TA 2003. Insulin and amino acids independently stimulate skeletal muscle protein synthesis in neonatal pigs. American Journal of Physiology 284, E110–E119.Google ScholarPubMed
Oddy, VH, Owens, PC 1996. Insulin-like growth factor I inhibits degradation and improves retention of protein in hindlimb muscle of lambs. American Journal of Physiology 271, E973–E982.Google ScholarPubMed
Ogawa, E, Breier, BH, Bauer, MK, Gallaher, BW, Grant, PA, Walton, PE, Owens, JA, Gluckman, PD 1996. Pretreatment with bovine growth hormone is as effective as treatment during metabolic stress to reduce catabolism in fasted lambs. Endocrinology 137, 1242–1248.CrossRefGoogle ScholarPubMed
Pell, JM, Hill, RA, Stewart, CEH, Weston, CR, Flick-Smith, HC 2000. Enhancement of insulin-like growth factor I activity by novel antisera: potential structure/function interactions. Endocrinology 141, 741–751.CrossRefGoogle ScholarPubMed
SAS 1999. SAS user’s guide (version 8). Statistical Analysis Systems Institute, Cary, NC.Google Scholar
Stewart, CEH, Bates, PC, Calder, TA, Woodall, SM, Pell, JM 1993. Potentiation of insulin-like growth factor-1 (IGF-1) activity by an antibody: supportive evidence for enhancement of IGF-1 bioavailability in vivo by IGF binding proteins. Endocrinology 133, 1462–1465.CrossRefGoogle ScholarPubMed
Thissen, J-P, Ketelslegers, J-M, Underwood, LE 1994. Nutritional regulation of the insulin-like growth factors. Endocrine Reviews 15, 80–101.Google ScholarPubMed
Thissen, J-P, Underwood, LE, Ketelslegers, J-M 1999. Regulation of insulin-like growth factor-I in starvation and injury. Nutrition Reviews 57, 167–176.CrossRefGoogle ScholarPubMed
Thissen, J-P, Davenport, ML, Pucilowska, JB, Miles, MV, Underwood, LE 1992. Increased serum clearance and degradation of 125I-labeled IGF-1 in protein restriced rats. American Journal of Physiology 262, E406–E411.Google Scholar
VandeHaar, MJ, Moats-Staats, BM, Davenport, ML, Walker, JL, Ketelslegers, J-M, Sharma, BK, Underwood, LE 1991. Reduced serum concentrations of insulin-like growth factor-I (IGF-I) in protein-restricted growing rats are accompanied by reduced IGF-I mRNA levels in liver and skeletal muscle. Journal of Endocrinology 130, 305–312.CrossRefGoogle ScholarPubMed
Villafuerte, BC, Fine, JB, Bai, Y, Zhao, W, Fleming, S, DiGirolamo, M 2000. Expressions of leptin and insulin-like growth factor-I are highly correlated and region specific in adipose tissue of growing rats. Obesity Research 8, 646–655.CrossRefGoogle ScholarPubMed
Wong, M-S, Fong, C-C, Yang, M 1999. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins. Biochimica et Biophysica Acta 1432, 293–301.CrossRefGoogle ScholarPubMed